{"title":"sEMG-based gesture recognition using multi-stream adaptive CNNs with integrated residual modules.","authors":"Yutong Xia, Dawei Qiu, Cheng Zhang, Jing Liu","doi":"10.3389/fbioe.2025.1487020","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Convolutional neural networks are widely used in gesture recognition research, which employs surface electromyography. However, when processing surface electromyography data, current deep learning models still face challenges, such as insufficient effective feature extraction, poor performance in multi-gesture recognition, and low accuracy in recognizing sparse surface electromyography.</p><p><strong>Methods: </strong>To address these issues, this study proposed a multi-stream adaptive convolutional neural networks with residual modules (MSACNN-RM) for surface electromyography gesture recognition, which integrates multiple streams of convolutional neural networks, adaptive convolutional neural networks, and residual modules to enhance the model's feature extraction and learning capabilities. This improves the model's ability to extract and understand complex data patterns.</p><p><strong>Results: </strong>The experimental results demonstrated that the model achieved recognition accuracies of 98.24%, 93.52%, and 92.27% respectively on the Ninapro DB1, Ninapro DB2, and Ninapro DB4 datasets. Compared with other deep learning models, MSACNN-RM achieves higher accuracy compared to existing models.</p><p><strong>Discussion: </strong>The proposed model explores features of sparse sEMG signals by leveraging multi-stream convolution, the combination of adaptive convolution modules and ResNet blocks enhances the model's ability of extracting crucial gesture features. In the future, in order to deal with differences in sEMG signals caused by variations among individuals, a universal multi-gesture recognition algorithm should be developed. Meanwhile, the model should focus on optimizing and streamlining the network to reduce computational load.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1487020"},"PeriodicalIF":4.3000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12069338/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1487020","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Convolutional neural networks are widely used in gesture recognition research, which employs surface electromyography. However, when processing surface electromyography data, current deep learning models still face challenges, such as insufficient effective feature extraction, poor performance in multi-gesture recognition, and low accuracy in recognizing sparse surface electromyography.
Methods: To address these issues, this study proposed a multi-stream adaptive convolutional neural networks with residual modules (MSACNN-RM) for surface electromyography gesture recognition, which integrates multiple streams of convolutional neural networks, adaptive convolutional neural networks, and residual modules to enhance the model's feature extraction and learning capabilities. This improves the model's ability to extract and understand complex data patterns.
Results: The experimental results demonstrated that the model achieved recognition accuracies of 98.24%, 93.52%, and 92.27% respectively on the Ninapro DB1, Ninapro DB2, and Ninapro DB4 datasets. Compared with other deep learning models, MSACNN-RM achieves higher accuracy compared to existing models.
Discussion: The proposed model explores features of sparse sEMG signals by leveraging multi-stream convolution, the combination of adaptive convolution modules and ResNet blocks enhances the model's ability of extracting crucial gesture features. In the future, in order to deal with differences in sEMG signals caused by variations among individuals, a universal multi-gesture recognition algorithm should be developed. Meanwhile, the model should focus on optimizing and streamlining the network to reduce computational load.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.